Skip to main content
55°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
3 Biotech Stocks That Could Boom or Bust in Q1
February 01, 2022
Tickers
OCGN
REGN
VRTX
Tags
VRTX
OCGN
Hot Stocks
From
InvestorPlace
5 Things To Expect This Week
January 31, 2022
Tickers
AAPL
AMD
AMZN
APPS
Tags
FB
PYPL
Market News
From
InvestorPlace
Analyst Ratings For Regeneron Pharmaceuticals
January 31, 2022
Tickers
REGN
Tags
Market News
REGN
BZI/AAR
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
REGN
HOLX
MRNA
From
Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
January 31, 2022
Tickers
REGN
SNY
Tags
SNY
Benzinga
Market News
From
Benzinga
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
January 31, 2022
Tickers
CTRA
LPX
MRNA
REGN
Tags
CTRA
MRNA
LPX
From
MarketWatch
A Deep Dive Into the Video Game Industry
January 29, 2022
Tickers
AAL
AAPL
AMZN
ATVI
Tags
PG
RH
REGN
From
Motley Fool
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
January 29, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
PFE
REGN
Market News
From
Motley Fool
Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use
January 28, 2022
Tickers
REGN
SNY
Tags
Cervical Cancer
Market News
General
From
Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Tickers
ALXO
BGNE
BIIB
IBB
Tags
General
Market News
IBB
From
Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
January 27, 2022
Tickers
BNTX
DRG
IBB
JNJ
Tags
IBB
XBI
NBI
From
MarketWatch
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
PFE
GSK
MRK
From
MarketWatch
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
January 25, 2022
Tickers
AXP
BRO
IBM
JNJ
Tags
NIO
Global
A Peek Into The Markets
From
Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
REGN
GILD
Antibodies
From
Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
Tickers
AZN
LLY
MRK
PFE
Tags
Health Care
PFE
MRK
From
Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
January 19, 2022
Tickers
REGN
SNY
Tags
REGN
Biotech
News
From
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Tickers
ADMA
ASLN
BGNE
CRDF
Tags
Biotech
FDA
Benzinga
From
Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
January 19, 2022
Tickers
REGN
Tags
News
FDA
Benzinga
From
Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
Tickers
MRK
MRNA
PFE
REGN
Tags
MRK
PFE
Market News
From
Motley Fool
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
Tickers
GSK
NVS
REGN
SNY
Tags
Recent Press Releases
SNY
REGN
From
Motley Fool
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
January 14, 2022
Tickers
GSK
LLY
REGN
VIR
Tags
Market News
COVID/19 Coronavirus
Benzinga
From
Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
January 13, 2022
Tickers
CNTB
IMAB
LLY
PFE
Tags
Biotech
IMAB
SNY
From
Benzinga
1 Key Ratio All Investors Should Be Looking at When Buying Growth Stocks in 2022
January 13, 2022
Tickers
ARKK
FUBO
REGN
TSLA
Tags
Market News
REGN
FUBO
From
Motley Fool
Why JPMorgan Is Among Rob Sechan's Top Picks For 2022
January 10, 2022
Tickers
EOG
JPM
REGN
Tags
EOG
REGN
why it's moving
From
Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
January 05, 2022
Tickers
PFE
REGN
Tags
Benzinga
PFE
Biotech
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Tickers
ACAD
ADBE
ADTH
AEL
Tags
AMGN
PFE
ADBE
From
Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
Tickers
ALGN
NTLA
REGN
SAVA
Tags
NTLA
ALGN
Recent Press Releases
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
Tickers
ACC
ADTH
ALNY
AVB
Tags
SAVE
Intraday Update
REG
From
Benzinga
Better Buy: CRISPR vs. Intellia
January 03, 2022
Tickers
BLUE
CRSP
NTLA
REGN
Tags
REGN
Recent Press Releases
NTLA
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Tickers
ALNY
ETON
IBB
NVS
Tags
RHHBY
ETON
NVS
From
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.